Use of CIPROXINA Simple with other medications
Inform your doctor or pharmacist that you are using, have used recently, or may need to use any other medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
This medication is not recommended during pregnancy. Do not use CIPROXINA Simple during pregnancy or breastfeeding, unless your doctor deems it necessary.
If you are breastfeeding your baby, do not use this medication as it may pass into breast milk.
Driving and operating machinery
The treatment with this medication does not affect your ability to drive and operate machinery.
CIPROXINA Simple contains benzalkonium chloride
This medication contains 0.06 mg of benzalkonium chloride per ml.
Benzalkonium chloride may cause skin irritation. Do not apply to mucous membranes.
This medicationshould onlybe administered via the otic route, that is, as ear drops. Follow exactly the administration instructions for this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Follow these instructions unless your doctor has given you different ones (such as when using an otowick, a sponge placed in the ear in some cases of external otitis to facilitate the absorption of the drops).
Remember to apply your medication when it is due.
Your doctor will indicate the duration of treatment with these drops. Do not suspend treatment beforehand, as it could harm the evolution of the healing of the affected ear.
The recommended dose is:
Adults: 4 drops in the ear, twice a day, morning and night.
Children:3 drops in the ear, twice a day, morning and night.
Usage recommendations:
Figure 1Figure 2
If a drop falls outside the ear, try again.
If you are using other ear drops, wait at least 5 minutes between the application of
CIPROXINA Simple and the other drops.
If you use more CIPROXINA Simple than you should,do not apply more drops until the next dose.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to use CIPROXINA Simple,apply a single dose as soon as you remember, and continue with the next dose that was scheduled. However, if it is almost time for the next dose, do not apply the missed dose and continue with the next dose of your regular regimen. Do not apply a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, CIPROXINA Simple may produce adverse effects, although not all people will experience them.
Less common adverse effects (may affect up to 1 in 100 people):
Adverse effects of unknown frequency (cannot be estimated from available data):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the reach and sight of children.
Do not use this medication after the expiration date that appears on the bottle and on the box after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Do not refrigerate or freeze.
Keep the bottle tightly closed.
To avoid infections, dispose of the bottle 4 weeks after first opening it.
Note the date of bottle opening in the designated space on the box.
Medications should not be disposed of through drains or trash. Deposit containers and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and unused medications. By doing so, you will help protect the environment.
Composition of CIPROXINA Simple
Appearance of the product and contents of the packaging
CIPROXINA Simple are eye drops in solution that are presented in 5 ml plastic bottles with screw-top caps.
Holder of the marketing authorization
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 – Barcelona, Spain
Responsible for manufacturing
Siegfried El Masnou, S.A.
C/Camil Fabra, 58
08320 El Masnou – Barcelona, Spain
or
Novartis Manufacturing NV
Rijksweg, 14
2870 Puurs-Sint-Amands, Belgium
or
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona, Spain
or
Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg, Germany
Last review date of this leaflet: April 2013
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.